查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1751223

醫藥保健活性碳市場規模、佔有率、趨勢分析報告：按類型、應用、地區、細分市場預測，2025-2030

Activated Carbon For Pharma & Healthcare Market Size, Share & Trends Analysis Report By Form (Powdered, Granular), By Application (API Production, Finished Drug Production), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 132 Pages | 商品交期: 2-10個工作天內

價格

製藥和醫療保健活性碳市場的成長和趨勢：

根據 Grand View Research, Inc. 的一份新報告，全球醫藥和保健活性碳市場預計到 2030 年將達到 6.521 億美元，2025 年至 2030 年的複合年成長率為 6.3%。

活性碳在製藥和醫療保健領域的需求持續成長，這主要歸功於其卓越的淨化和吸附污染物的能力。在醫院，活性碳在維持空氣和水質清潔方面發揮著至關重要的作用；在製藥業，活性碳則用於去除藥品中的雜質和不必要的色素。醫用級活性碳已獲準用於人體，也是急診醫學中治療毒性中毒的重要工具。活性碳能夠與消化道中的毒素結合，阻止其被人體吸收。

每年約有170萬名患者（約佔住院患者的5%至10%）患有醫院內感染（HAI），導致近10萬人死亡。這一數字凸顯了醫院內感染這一嚴重的公共衛生問題，其影響遠超過許多其他重大疾病。為了解決這個問題，醫療機構正在轉向先進的淨化技術，而活性碳因其能夠有效過濾有害顆粒和病原體而成為首選。

此外，活性碳因其高孔隙率和優異的吸附能力，在製藥業已廣泛應用。這些特性使其能夠有效去除藥品生產過程中的污染物、色素和殘留物，從而提高最終產品的品質和安全性。

製藥和醫療保健活性碳市場亮點

  • 從形式來看，粉末狀將在 2024 年佔據市場主導地位，銷售佔有率最大，為 56.3%。
  • 預計在市場估計和預測期內，製藥和醫療保健領域的顆粒活性碳市場將以最快的複合年成長率成長。
  • 其成長動力源自於其高吸收性、易於處理和儲存以及承受重複過濾循環的能力。
  • 根據應用，原料藥製造將引領製藥和醫療保健行業的活性碳市場，並在 2024 年佔據最大的收益佔有率。
  • 預計預測期內成品藥製造領域將以 6.2% 的顯著複合年成長率成長。
  • 到 2024 年，亞太地區將佔據全球市場主導地位，收益佔有率最高，為 48.6%。
  • 亞洲國家藥品生產的增加刺激了對生產過程中更有效率的精製方法的需求。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章 醫藥和醫療保健用活性碳的市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關市場展望
  • 產業價值鏈分析
  • 法律規範
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業挑戰
    • 行業機會
  • 產業分析工具
    • 波特五力分析
    • 宏觀環境分析

第4章醫藥和保健活性碳市場：形態評估和趨勢分析

  • 細分儀表板
  • 醫藥和醫療保健用活性碳市場：形態變異分析和市場佔有率（2024 年和 2030 年）
  • 粉末
  • 顆粒狀
  • 其他形式

第5章：醫藥和保健活性碳市場：應用估算和趨勢分析

  • 細分儀表板
  • 醫藥和醫療保健活性碳市場：應用趨勢分析和市場佔有率，2024 年和 2030 年
  • API 製造
    • 製藥和醫療保健市場收益估計和預測（API 製造領域，2018-2030 年）
  • 成品藥生產
    • 醫藥和醫療保健市場收益估計和預測（成品藥產量，2018-2030 年）
  • 其他
    • 2018-2030年製藥和醫療保健市場活性碳收益估計和預測（其他應用）

第6章：醫藥和保健活性碳市場：區域估計和趨勢分析

  • 2024 年和 2030 年區域趨勢分析和市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯

7. 醫藥與保健活性碳市場-競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖
  • 2024年排名分析
  • 戰略地圖
    • 擴張
    • 合併與收購
    • 夥伴關係和合作
    • 新表格發布
    • 研究與開發
  • 公司簡介
    • Jacobi Group
    • Chemviron（a Kuraray Company）
    • Haycarb PLC
    • Boyce Carbon
    • Southern Carbon Pvt. Ltd.
    • Suneeta Carbons
    • Calgon Carbon Corporation
    • Karbonous Inc.
    • Norit
    • Donau Carbon GmbH
Product Code: GVR-4-68040-564-7

Activated Carbon For Pharma & Healthcare Market Growth & Trends:

The global activated carbon for pharma & healthcare market size is anticipated to reach USD 652.1 million by 2030 and is expected to grow at a CAGR of 6.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The demand for activated carbon in the pharmaceutical and healthcare sectors continues to grow, largely due to its exceptional ability to purify and adsorb contaminants. In hospitals, it plays a vital role in maintaining clean air and water, while in pharmaceutical manufacturing, it's used to remove impurities and unwanted colorants from medications. Medical-grade activated carbon, approved for human use, is also a critical tool in emergency medicine for treating poisonings. It works by binding to toxins in the gastrointestinal tract, stopping them from being absorbed into the body, a life-saving measure in cases of overdose or accidental ingestion.

This rising demand is also tied to the significant challenge posed by hospital-acquired infections (HAIs) in the U.S. Each year, approximately 1.7 million patients, roughly 5% to 10% of those hospitalized, develop an HAI, with close to 100,000 resulting deaths. These numbers highlight a serious public health concern that exceeds the impact of many other major diseases. To combat this, healthcare facilities are turning to advanced purification technologies, with activated carbon being a top choice due to its efficiency in filtering harmful particles and pathogens.

In addition, activated carbon is heavily utilized in the pharmaceutical industry for its high porosity and excellent adsorption capabilities, which are enhanced through thermal processing. These properties allow it to effectively remove contaminants, pigments, and residues during drug production, improving the final product's quality and safety.

Activated Carbon For Pharma & Healthcare Market Highlights

  • Based on form, the powdered form dominated the market with the largest revenue share of 56.3% in 2024.
  • The granular activated carbon market for the pharmaceutical and healthcare industry is estimated to grow at the fastest CAGR over the forecast period.
  • Its superior absorption, easy handling, storage, and ability to withstand repeated filtration cycles drive the growth.
  • Based on application, API production led the activated carbon market for the pharma & healthcare industry, accounting for the largest revenue share in 2024.
  • The finished drug production segment is expected to grow at a significant CAGR of 6.2% over the forecast period.
  • Asia Pacific dominated the global market with the largest revenue share of 48.6% in 2024.
  • The rise in pharmaceutical production across Asian countries fueled the demand for more efficient purification methods during production.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Activated Carbon For Pharma & Healthcare Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related Market Outlook
  • 3.2. Industry Value Chain Analysis
  • 3.3. Regulatory Framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Industry Challenges
    • 3.4.4. Industry Opportunities
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. Macro-environmental Analysis

Chapter 4. Activated Carbon For Pharma & Healthcare Market: Form Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Activated Carbon For Pharma & Healthcare Market: Form Movement Analysis & Market Share, 2024 & 2030
  • 4.3. Powdered
    • 4.3.1. Powdered Form Market Revenue Estimates and Forecasts, 2018 - 2030 (Kilotons, USD Million)
  • 4.4. Granular
    • 4.4.1. Granular Form Market Revenue Estimates and Forecasts, 2018 - 2030 (Kilotons, USD Million)
  • 4.5. Other Form
    • 4.5.1. Other Form Market Revenue Estimates and Forecasts, 2018 - 2030 (Kilotons, USD Million)

Chapter 5. Activated Carbon For Pharma & Healthcare Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Activated Carbon For Pharma & Healthcare Market: Application Movement Analysis & Market Share, 2024 & 2030
  • 5.3. API Production
    • 5.3.1. Activated Carbon For Pharma & Healthcare Market Revenue Estimates and Forecasts, in API Production, 2018 - 2030 (Kilotons, USD Million)
  • 5.4. Finished Drug Production
    • 5.4.1. Activated Carbon For Pharma & Healthcare Market Revenue Estimates and Forecasts, in Finished Drug Production, 2018 - 2030 (Kilotons, USD Million)
  • 5.5. Others
    • 5.5.1. Activated Carbon For Pharma & Healthcare Market Revenue Estimates and Forecasts, in Other Applications, 2018 - 2030 (Kilotons, USD Million)

Chapter 6. Activated Carbon For Pharma & Healthcare Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Movement Analysis & Market Share, 2024 & 2030
  • 6.2. North America
    • 6.2.1. North America activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key country dynamics
      • 6.2.2.2. U.S. activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key country dynamics
      • 6.2.3.2. Canada activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key country dynamics
      • 6.2.4.2. Mexico activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
  • 6.3. Europe
    • 6.3.1. Europe activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Germany activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.3. UK
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. UK activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. France activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key country dynamics
      • 6.3.5.2. Italy activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key country dynamics
      • 6.3.6.2. Spain activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.2. China
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. China activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.3. India
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. India activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.4. Japan
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Japan activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. South Korea activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Australia activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Brazil activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Argentina activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
  • 6.6. Middle East & Africa
    • 6.6.1. Middle East & Africa activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. South Africa activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Saudi Arabia activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)

Chapter 7. Activated Carbon For Pharma & Healthcare Market - Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map
  • 7.4. Position Analysis, 2024
  • 7.5. Strategy Mapping
    • 7.5.1. Expansion
    • 7.5.2. Mergers & Acquisition
    • 7.5.3. Partnerships & Collaborations
    • 7.5.4. New Form Launches
    • 7.5.5. Research And Development
  • 7.6. Company Profiles
    • 7.6.1. Jacobi Group
      • 7.6.1.1. Participant's overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Form benchmarking
      • 7.6.1.4. Recent developments
    • 7.6.2. Chemviron (a Kuraray Company)
      • 7.6.2.1. Participant's overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Form benchmarking
      • 7.6.2.4. Recent developments
    • 7.6.3. Haycarb PLC
      • 7.6.3.1. Participant's overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Form benchmarking
      • 7.6.3.4. Recent developments
    • 7.6.4. Boyce Carbon
      • 7.6.4.1. Participant's overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Form benchmarking
      • 7.6.4.4. Recent developments
    • 7.6.5. Southern Carbon Pvt. Ltd.
      • 7.6.5.1. Participant's overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Form benchmarking
      • 7.6.5.4. Recent developments
    • 7.6.6. Suneeta Carbons
      • 7.6.6.1. Participant's overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Form benchmarking
      • 7.6.6.4. Recent developments
    • 7.6.7. Calgon Carbon Corporation
      • 7.6.7.1. Participant's overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Form benchmarking
      • 7.6.7.4. Recent developments
    • 7.6.8. Karbonous Inc.
      • 7.6.8.1. Participant's overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Form benchmarking
      • 7.6.8.4. Recent developments
    • 7.6.9. Norit
      • 7.6.9.1. Participant's overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Form benchmarking
      • 7.6.9.4. Recent developments
    • 7.6.10. Donau Carbon GmbH
      • 7.6.10.1. Participant's overview
      • 7.6.10.2. Financial performance
      • 7.6.10.3. Form benchmarking
      • 7.6.10.4. Recent developments

List of Tables

  • Table 1. List of abbreviations
  • Table 2. Activated carbon for pharma & healthcare market 2018 - 2030 (Kilotons) (USD Million)
  • Table 3. Global activated carbon for pharma & healthcare market estimates and forecasts by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 4. Global activated carbon for pharma & healthcare market estimates and forecasts by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 5. Global activated carbon for pharma & healthcare market estimates and forecasts by region, 2018 - 2030 (Kilotons) (USD Million)
  • Table 6. North America activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 7. North America activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 8. North America activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 9. U.S. activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 10. U.S. activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 11. Canada activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 12. Canada activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 13. Mexico activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 14. Mexico activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 15. Europe activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 16. Europe activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 17. Europe activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 18. Germany activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 19. Germany activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 20. UK activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 21. UK activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 22. France activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 23. France activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 24. Italy activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 25. Italy activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 26. Spain activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 27. Spain activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 28. Asia Pacific activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 29. Asia Pacific activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 30. Asia Pacific activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 31. China activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 32. China activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 33. India activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 34. India activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 35. Japan activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 36. Japan activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 37. South Korea activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 38. South Korea activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 39. Australia activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 40. Australia activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 41. Latin America activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 42. Latin America activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 43. Latin America activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 44. Brazil activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 45. Brazil activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 46. Argentina activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 47. Argentina activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 48. Middle East & Africa activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 49. Middle East & Africa activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 50. Middle East & Africa activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 51. South Africa activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 52. South Africa activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 53. Saudi Arabia activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 54. Saudi Arabia activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 QFD Modeling for Market Share Assessment
  • Fig. 6 Information Procurement
  • Fig. 7 Market Formulation and Validation
  • Fig. 8 Data Validating & Publishing
  • Fig. 9 Market Segmentation & Scope
  • Fig. 10 Activated Carbon For Pharma & Healthcare Market Snapshot
  • Fig. 11 Form Segment Snapshot (1/2)
  • Fig. 12 Application Segment Snapshot (1/2)
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent market outlook
  • Fig. 15 Activated Carbon For Pharma & Healthcare Market Value, 2024 (Kilotons) (USD Million)
  • Fig. 16 Activated Carbon For Pharma & Healthcare Market - Value Chain Analysis
  • Fig. 17 Activated Carbon For Pharma & Healthcare Market - Market Dynamics
  • Fig. 18 Activated Carbon For Pharma & Healthcare Market - PORTER's Analysis
  • Fig. 19 Activated Carbon For Pharma & Healthcare Market - PESTEL Analysis
  • Fig. 20 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, By Form: Key Takeaways
  • Fig. 21 Activated Carbon For Pharma & Healthcare Market Share, By Form, 2024 & 2030
  • Fig. 22 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Powdered Form, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 23 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Granular Form, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 24 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, By Application: Key Takeaways
  • Fig. 25 Activated Carbon For Pharma & Healthcare Market Share, By Application, 2024 & 2030
  • Fig. 26 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in API Production, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 27 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Finished Drug Production, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 28 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Others, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 29 Activated Carbon For Pharma & Healthcare Market Revenue, By Region, 2024 & 2030 (Kilotons) (USD Million)
  • Fig. 30 North America Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 31 U.S. Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 32 Canada Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 33 Mexico Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 34 Europe Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 35 Germany Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 36 UK Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 37 France Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 38 Italy Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 39 Spain Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 40 Asia Pacific Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 41 China Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 42 India Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 43 Japan Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 44 South Korea Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 45 Australia Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 46 Latin America Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 47 Brazil Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 48 Argentina Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 49 Middle East & Africa Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 50 South Africa Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 51 Saudi Arabia Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 52 Key Company Categorization
  • Fig. 53 Company Market Positioning
  • Fig. 54 Strategy Mapping